Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low

Lin Wang1, Huanchun Xing2, Shuai Guo3

  • 1State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, China.

Drug Delivery
|June 13, 2023
PubMed

Insights

Researchers developed a safer messenger RNA (mRNA) delivery system by adding anionic lipids to neutralize toxic cationic lipids. This approach enhances safety while maintaining effective mRNA transfection for potential therapeutic applications.

Area of Science:

  • Biotechnology
  • Drug Delivery Systems
  • Molecular Biology

Background:

  • Messenger RNA (mRNA) therapeutics show great promise but face delivery challenges due to fragility and degradation.
  • Cationic lipids are essential for mRNA delivery systems (DS) but pose significant biosafety risks due to high toxicity.
  • Developing safe and efficient mRNA delivery systems is critical for therapeutic success.

Purpose of the Study:

  • To develop a novel, safer mRNA delivery system by incorporating negatively charged phospholipids.
  • To neutralize the positive charge of cationic lipids, thereby mitigating toxicity.
  • To investigate factors influencing mRNA transfection efficiency from cellular to animal levels.

Main Methods:

  • Synthesized a new mRNA delivery system (DS) by combining cationic lipids with negatively charged phospholipids.
  • Optimized DS parameters including lipid composition, proportions, structure, and transfection time.
  • Evaluated the impact of anionic lipid addition on safety and transfection efficiency in vitro and in vivo.

Main Results:

  • The developed mRNA DS successfully neutralized the positive charge of cationic lipids using anionic phospholipids.
  • Adding an appropriate amount of anionic lipid increased the safety profile of the delivery system.
  • The modified DS maintained high mRNA transfection efficiency comparable to traditional cationic systems.
  • Factors affecting mRNA transfection were identified, guiding further optimization.

Conclusions:

  • Incorporating anionic lipids into liposomal delivery systems is a viable strategy to enhance mRNA therapeutic safety.
  • This approach offers a promising balance between reduced toxicity and preserved transfection efficacy.
  • Further research into mRNA encapsulation and release kinetics is necessary for optimal in vivo delivery system design.

Related Concept Videos